Europe adopts compromise position on reduced risk products to beat cancer

The European Parliament has overwhelmingly adopted the Special Committee on Beating Cancer (BECA) report in a move that marks the first time a European institution has formally acknowledged reduced risk products could play a role in smoking cessation – with some caveats.

The parliament voted 652 in favour, 15 against and 27 abstaining during last week’s plenary session. The approved plan included “compromise amendments” on alternatives approved by 29 of 34 committee members in December.

Read full article
I'm already a subscriber

Antonia Di Lorenzo

Assistant news editor/senior reporter
Antonia is a member of the editorial team and holds a masters degree in Law from the University of Naples Federico II, Italy. She moved in 2013 to London, where she completed a postgraduate course at the London School of Journalism. In the UK, she worked as a news reporter for a financial newswire and a magazine before moving to Barcelona in 2019.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation